FDA Safety Warning on the Cardiac Effects of Lamotrigine: An Advisory From the Ad Hoc ILAE/AES Task Force - Sorbonne Université
Journal Articles Epilepsy Currents Year : 2021

FDA Safety Warning on the Cardiac Effects of Lamotrigine: An Advisory From the Ad Hoc ILAE/AES Task Force

Domains

Life Sciences [q-bio]
Fichier principal
Vignette du fichier
1535759721996344.pdf (519.14 Ko) Télécharger le fichier
Origin Publication funded by an institution

Gestionnaire HAL 4 Sorbonne Université  : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03179099

Submitted on : Wednesday, March 24, 2021-10:31:07 AM

Last modification on : Thursday, December 14, 2023-1:50:38 PM

Download

Dates and versions

hal-03179099 , version 1 (24-03-2021)

Identifiers

Cite

Jacqueline A French, Emilio Perucca, Josemir W Sander, Lennart Bergfeldt, Michel Baulac, et al.. FDA Safety Warning on the Cardiac Effects of Lamotrigine: An Advisory From the Ad Hoc ILAE/AES Task Force. Epilepsy Currents, 2021, pp.153575972199634. ⟨10.1177/1535759721996344⟩. ⟨hal-03179099⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

INSERM CNRS ICM SORBONNE-UNIVERSITE SU-MEDECINE
16 View
71 Download

Altmetric

Share

More